Radiopharmacy service: Clatterbridge Cancer Centre seeks supplier views
- The Clatterbridge Cancer Centre NHS Foundation Trust
- North West
- 1 April 2028 to 1 April 2038
The Clatterbridge Cancer Centre NHS Foundation Trust plans to buy a radiopharmaceuticals service for its nuclear medicine, PET-CT and related diagnostic and therapy work. It has asked suppliers for expressions of interest and feedback to shape the requirement.
The service must include a fully established cyclotron radiopharmacy that produces labelled radioisotopes for cancer diagnosis and treatment. It must also supply Tc-99m radiopharmaceuticals, from a generator or a cyclotron, and Lu-177 radiopharmaceuticals. The trust may add equipment maintenance, waste disposal, PET radiotracers and support for emerging treatments.
The trust has published no estimate. It outlines a 10-year contract from April 2028, and says these dates are provisional.
- What
- Radiopharmaceuticals and contrast media
- Estimated value
- Not published
- How it will be bought
- Not published
- Responses due
- 10 Nov 2026
- Contract dates
- Apr 2028 to Apr 2038